Vascular Genesis

Vascular Genesis is a private U.S. medical device and regenerative medicine company developing cell-free, synthetic scaffold products for vascular conduit replacement. Its lead focus is a resorbable arteriovenous graft for dialysis access intended to remodel into native vascular tissue over time. The company positions its technology as an alternative to donated tissue and permanent synthetic grafts, with the goal of reducing rejection, infection, stenosis, and the need for immunosuppression. Vascular Genesis appears to be part of the ParaGen Technologies ecosystem of scaffold-based tissue engineering companies in Ohio. Publicly available information suggests the company remains private and active, but with a very limited disclosed pipeline and no clearly reported clinical-stage programs.